BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1691392)

  • 1. Epinephrine-induced enhancement of sympathetic activity in humans: inhibition by nonselective as well as beta 1-selective beta-adrenoceptor blockade.
    van den Meiracker AH; Man in 't Veld AJ; Boomsma F; Blankestijn PJ; Schalekamp MA
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):610-7. PubMed ID: 1691392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenaline-induced amplification of sympathetic activity during rest and stress: inhibition by non-selective and beta 1-selective beta-adrenoceptor blockade.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Blankestijn PJ; Schalekamp MA
    J Hypertens Suppl; 1988 Dec; 6(4):S558-61. PubMed ID: 2907349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of selective beta 1 and nonselective beta-adrenoceptor blockade on epinephrine and atropine response in normal humans.
    Gullestad L; Forfang K; Simonsen S
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):976-81. PubMed ID: 1282602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mental and physical stress on plasma catecholamine levels before and after beta-adrenoceptor blocker treatment.
    Paran E; Neumann L; Cristal N
    Eur J Clin Pharmacol; 1992; 43(1):11-5. PubMed ID: 1354617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
    McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG
    Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma catecholamine responses to exercise after training with beta-adrenergic blockade.
    Wolfel EE; Hiatt WR; Brammell HL; Travis V; Horwitz LD
    J Appl Physiol (1985); 1990 Feb; 68(2):586-93. PubMed ID: 1969402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
    Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term beta 1-adrenergic blockade restores adrenomedullary activity in primary hypertension.
    Jacobs MC; Lenders JW; Smits P; Willemsen JJ; Tack C; Thien T
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):338-42. PubMed ID: 9300318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the short-term beta-adrenoceptor blockade on exercise metabolism in cold weather.
    Lehtonen A; Huupponen R; Himanen P
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):86-90. PubMed ID: 6142007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers.
    Nieminen MS; Rapola J; Pellinen TJ; Toivonen L
    Ann Clin Res; 1988; 20(6):431-5. PubMed ID: 2905879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of norepinephrine release by peripheral presynaptic beta-adrenoceptors.
    Chang PC; Kriek E; van der Krogt JA; Blauw GJ; van Brummelen P
    Clin Exp Hypertens A; 1989; 11 Suppl 1():311-21. PubMed ID: 2545385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria.
    Hosohata Y; Hattori K; Shen Y; Okuyama M; Kaneko H; Ohnuki T; Suzuki J; Nagatomo T
    Pharmacology; 1998 Oct; 57(4):180-7. PubMed ID: 9730775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.
    Schiess W; Welzel D; Gugler R
    Eur J Clin Pharmacol; 1984; 27(5):529-34. PubMed ID: 6151506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical pharmacology of bopindolol, a new long-acting beta-adrenoceptor antagonist, in hypertension.
    van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Derkx FH; Mulder P; Schalekamp MA
    Clin Pharmacol Ther; 1987 Oct; 42(4):411-9. PubMed ID: 2889554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of the beta 1-selectivity of single doses of bisoprolol and atenolol.
    Chang PC; van Veen S; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S58-60. PubMed ID: 2439799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous versus arterial forearm catecholamines as an index of overall sympatho-adrenomedullary activity.
    van den Meiracker AH; Man in 't Veld AJ; Boomsma F; Schalekamp MA
    Clin Exp Hypertens A; 1989; 11 Suppl 1():345-51. PubMed ID: 2743596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-blockade, atrial natriuretic peptide and exercise.
    Kantola I; Tarssanen L; Scheinin M; Ruskoaho H; Viinamäki O; Kaila T
    Int J Clin Pharmacol Ther; 1996 Jan; 34(1):12-6. PubMed ID: 8688991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and metabolic responses to exercise after adrenoceptor blockade in humans.
    McLeod AA; Brown JE; Kitchell BB; Sedor FA; Kuhn C; Shand DG; Williams RS
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Mar; 56(3):716-22. PubMed ID: 6142878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.